Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999–2000

This publication has 30 references indexed in Scilit:

• Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates
  International Journal of Antimicrobial Agents, 2001
• Levofloxacin-Resistant Streptococcus pneumoniae : Second Look
  Antimicrobial Agents and Chemotherapy, 2001
• Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis
  Antimicrobial Agents and Chemotherapy, 2001
• Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United States
  New England Journal of Medicine, 2000
• The Use of Levofloxacin in the Treatment of Respiratory Tract Infection
  Journal of Chemotherapy, 2000
• Benchmarking the In Vitro Activities of Moxifloxacin and Comparator Agents against Recent Respiratory Isolates from 377 Medical Centers throughout the United States
  Antimicrobial Agents and Chemotherapy, 2000
• Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States
  Antimicrobial Agents and Chemotherapy, 2000
• Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study
  Diagnostic Microbiology and Infectious Disease, 2000
• Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998
  Journal of Antimicrobial Chemotherapy, 2000
• Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in Canada
  New England Journal of Medicine, 1999